Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• In Q4 2025, Current Leases rose 1.68% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 1.68% YoY), while the FY2025 annual figure was $1.6 million, up 1.68% from the prior year.
• Current Leases was $1.6 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $1.7 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.7 million in Q3 2025 to a low of $1.0 million in Q1 2021.
• Historically, Current Leases has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Current Leases soared 39.49% in 2021, then grew 1.68% in 2025.
• A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then increased by 12.66% to $1.3 million in 2022, then grew by 12.19% to $1.4 million in 2023, then grew by 11.76% to $1.6 million in 2024, then rose by 1.68% to $1.6 million in 2025.
• The last three Current Leases figures came in at $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.